Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues Quatresooz P; Pierard-Franchimont C; Paquet P; Hubert P; Delvenne P; Pierard GEEur J Dermatol 2008[Jan]; 18 (1): 6-10Actinic keratoses (AKs) and their derived squamous cell carcinomas are distinctive lesions forming a continuum in a multi-step carcinogenesis process. They are typically found on chronically sun exposed skin. AKs merit to be recognized as such and to be distinguished from squamous cell carcinomas both conceptually and for therapeutic implications. The histological differences between these lesions are well defined and should not be blurred. A brief review is presented about the biological features responsible for AKs and the clinicopathologically distinctive aspects of these lesions. In addition, recent findings are presented about pharmacotherapy using anti-epidermal growth factor receptors, imidazoquinolines, diclofenac-hyaluronan, and methyl aminolevulinate photodynamic therapy.|Aminoquinolines/therapeutic use[MESH]|Antineoplastic Agents/*therapeutic use[MESH]|Carcinoma, Squamous Cell/*diagnosis/drug therapy/pathology[MESH]|ErbB Receptors/antagonists & inhibitors[MESH]|Humans[MESH]|Imiquimod[MESH]|Keratosis/*diagnosis/drug therapy/etiology/pathology[MESH]|Photochemotherapy[MESH]|Precancerous Conditions/*diagnosis/drug therapy/etiology/pathology[MESH]|Skin Neoplasms/*diagnosis/drug therapy/pathology[MESH]|Sunlight/*adverse effects[MESH] |
